Submitted by Anonymous (not verified) on 14 November 2025 - 15:30
Human medicines European public assessment report (EPAR): Anagrelide Viatris (previously Anagrelide Mylan), anagrelide, Date of authorisation: 15/02/2018, Revision: 12, Status: Authorised
Source: